Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Mutant GTPase KRAS inhibitors discovered at Beijing Jacobio Pharmaceuticals

March 1, 2021

New cyclin-dependent kinase inhibitors identified at Chengdu Synowest Biotechnology

March 1, 2021

P2RX7 activator HEI-3090 shows promise for treating NSCLC

March 1, 2021

Targeting the LIGHT/LTbR pathway may be a strategy to eliminate leukemia stem cells

March 1, 2021

First patient dosed in phase I/II study of KB-0742

Feb. 26, 2021

Italian researchers present new PTPN11 inhibitors

Feb. 26, 2021

Well Marker Bio presents new MST1R inhibitors

Feb. 26, 2021

ESSA Pharma and Astellas collaborate to investigate EPI-7386 plus enzalutamide in mCRPC

Feb. 26, 2021

Targeting of neoplastic progenitors as new therapeutic strategy in AML

Feb. 26, 2021

Bacterial protease takes on "undruggable" oncoprotein

Feb. 25, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Viva in vivo! At EHA, in vivo CAR T data continues to impress
BioWorld
Treatment with first-generation CAR T cells regularly sent patients to the intensive care unit. Now, investigators are envisioning a future where CAR T treatment...